Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease

Liver transplantation is the only effective treatment modality for end-stage liver disease. However, donor organs are not always available. In some cases, the gravity of the patient’s condition makes transplantation impossible. In this regard, the use of artificial liver support systems helps in pre...

Full description

Bibliographic Details
Main Authors: A. G. Strokov, I. L. Poz, A. R. Monakhov, S. V. Meshcheryakov, M. A. Voskanov, S. V. Gautier
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-10-01
Series:Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/1225
_version_ 1797871969567244288
author A. G. Strokov
I. L. Poz
A. R. Monakhov
S. V. Meshcheryakov
M. A. Voskanov
S. V. Gautier
author_facet A. G. Strokov
I. L. Poz
A. R. Monakhov
S. V. Meshcheryakov
M. A. Voskanov
S. V. Gautier
author_sort A. G. Strokov
collection DOAJ
description Liver transplantation is the only effective treatment modality for end-stage liver disease. However, donor organs are not always available. In some cases, the gravity of the patient’s condition makes transplantation impossible. In this regard, the use of artificial liver support systems helps in preparing a patient for transplant surgery. Objective: to conduct a retrospective study aimed at evaluating the efficiency of fractionated plasma separation and adsorption system. Materials and methods. From January 2019 to May 2020, 139 pediatric liver transplants were. We analyzed the data of 5 pediatric patients (2 girls and 3 boys, aged 12 to 17 years) who received fractionated plasma separation and adsorption (FPSA) sessions as a bridge to transplantation. The main clinical indication for FPSA was severe hepatic encephalopathy (grade 3 according to the West Haven Criteria), which was observed at 350–872 μmol/L (average 597 ± 98 μmol/L) serum bilirubin level. The FPSA sessions were conducted on a Prometheus device using AV-600 hemofilters as dialyzers (Fresenius Medical Care, Germany). Results. Depending on the extent of bilirubinemia in patients, it took from one (in one case) to three (in one case) daily FPSA sessions to restore clear consciousness, appetite and physical activity. Average bilirubin levels after treatment cycles decreased from 597 ± 98 to 236 ± 73 μmol/L. All patients successfully underwent liver transplant surgery within two to five days, two patients received a liver fragment from a living related donor. Conclusion. The FPSA system stabilizes the condition of potential recipients with acute liver failure. Further research is required to develop optimal regimens for albumin dialysis.
first_indexed 2024-04-10T00:52:31Z
format Article
id doaj.art-f18a670c2e8e42cf97cda877a464f64c
institution Directory Open Access Journal
issn 1995-1191
language Russian
last_indexed 2024-04-10T00:52:31Z
publishDate 2020-10-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Vestnik Transplantologii i Iskusstvennyh Organov
spelling doaj.art-f18a670c2e8e42cf97cda877a464f64c2023-03-13T10:37:26ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovVestnik Transplantologii i Iskusstvennyh Organov1995-11912020-10-01223364210.15825/1995-1191-2020-3-36-42893Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver diseaseA. G. Strokov0I. L. Poz1A. R. Monakhov2S. V. Meshcheryakov3M. A. Voskanov4S. V. Gautier5Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityShumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityShumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial OrgansShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityLiver transplantation is the only effective treatment modality for end-stage liver disease. However, donor organs are not always available. In some cases, the gravity of the patient’s condition makes transplantation impossible. In this regard, the use of artificial liver support systems helps in preparing a patient for transplant surgery. Objective: to conduct a retrospective study aimed at evaluating the efficiency of fractionated plasma separation and adsorption system. Materials and methods. From January 2019 to May 2020, 139 pediatric liver transplants were. We analyzed the data of 5 pediatric patients (2 girls and 3 boys, aged 12 to 17 years) who received fractionated plasma separation and adsorption (FPSA) sessions as a bridge to transplantation. The main clinical indication for FPSA was severe hepatic encephalopathy (grade 3 according to the West Haven Criteria), which was observed at 350–872 μmol/L (average 597 ± 98 μmol/L) serum bilirubin level. The FPSA sessions were conducted on a Prometheus device using AV-600 hemofilters as dialyzers (Fresenius Medical Care, Germany). Results. Depending on the extent of bilirubinemia in patients, it took from one (in one case) to three (in one case) daily FPSA sessions to restore clear consciousness, appetite and physical activity. Average bilirubin levels after treatment cycles decreased from 597 ± 98 to 236 ± 73 μmol/L. All patients successfully underwent liver transplant surgery within two to five days, two patients received a liver fragment from a living related donor. Conclusion. The FPSA system stabilizes the condition of potential recipients with acute liver failure. Further research is required to develop optimal regimens for albumin dialysis.https://journal.transpl.ru/vtio/article/view/1225cirrhosisliver failurealbumin dialysisliver transplantationpediatric liver transplantationextracorporeal liver supporthepatic encephalopathyfractionated plasma separation and adsorption
spellingShingle A. G. Strokov
I. L. Poz
A. R. Monakhov
S. V. Meshcheryakov
M. A. Voskanov
S. V. Gautier
Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
Vestnik Transplantologii i Iskusstvennyh Organov
cirrhosis
liver failure
albumin dialysis
liver transplantation
pediatric liver transplantation
extracorporeal liver support
hepatic encephalopathy
fractionated plasma separation and adsorption
title Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
title_full Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
title_fullStr Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
title_full_unstemmed Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
title_short Efficacy of albumin dialysis as a bridge to transplantation in children with end-stage liver disease
title_sort efficacy of albumin dialysis as a bridge to transplantation in children with end stage liver disease
topic cirrhosis
liver failure
albumin dialysis
liver transplantation
pediatric liver transplantation
extracorporeal liver support
hepatic encephalopathy
fractionated plasma separation and adsorption
url https://journal.transpl.ru/vtio/article/view/1225
work_keys_str_mv AT agstrokov efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease
AT ilpoz efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease
AT armonakhov efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease
AT svmeshcheryakov efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease
AT mavoskanov efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease
AT svgautier efficacyofalbumindialysisasabridgetotransplantationinchildrenwithendstageliverdisease